GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Other Income (Expense)

Daito Pharmaceutical Co (TSE:4577) Other Income (Expense) : 円339 Mil (TTM As of Feb. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Other Income (Expense)?

Daito Pharmaceutical Co's other income expense for the Daito Pharmaceutical Co's pretax income for the three months ended in Feb. 2024 was 円322 Mil. Its other income expense for the trailing twelve months (TTM) ended in Feb. 2024 was 円339 Mil.


Daito Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for Daito Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Other Income (Expense) Chart

Daito Pharmaceutical Co Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.94 249.18 -28.00 176.00 -120.00

Daito Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.00 -18.00 14.00 21.00 322.00

Daito Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円339 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daito Pharmaceutical Co  (TSE:4577) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Daito Pharmaceutical Co (TSE:4577) Business Description

Traded in Other Exchanges
N/A
Address
326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co (TSE:4577) Headlines

No Headlines